Abstract:Single-cell capture and in situ analysis of circulating tumor cells (CTCs) in blood are of great significance for early cancer diagnosis, prognosis, and individualized treatment. However, designing an all-in-one platform that enables not only efficiently specific isolation of CTCs but also in situ analysis of heterogeneity and drug screening is challenging. Here, a cell-imprinted alginate hydrogel (CIAH) interface with all-in-one functions was developed for the capture, in situ analysis, and drug-response study at a single-cell level. Based on the equivalent morphology and "specific odor" left by template cells and supplemented by natural antibody, the CIAH interface exhibited outstanding performance in isolating CTCs from samples suffering from cancers. Beyond capture, the CIAH interface was also able to serve as a high-throughput platform for subpopulation analysis and drug response of heterogeneous CTCs. We demonstrated that the highly integrated multifunctional CIAH interface is a promising new tool for single-cell profiling of phenotypic heterogeneity and guiding of personalized anticancer therapy.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.1c00577?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.1c00577</a>.Statistical average values of imprint cavities and the profiling of an individual imprinted cavity measured by AFM; characterization of surface functionalization; fluorescence images of MCF-7 cells stained with AO/EB; MCF-7 cells capture efficiency versus incubation time; comparison of cell capture efficiency on CIAH interfaces made with living and inactivated MCF-7 cells; capture efficiency of MDA-MB-231 cells on flat and MCF-7-imprinted substrates; fluorescence images of selectivity of the MCF-7-imprinted interfaces; fluorescence images of CTCs captured from the breast cancer samples after TAM treatment; and summary of literatures on cell-imprinted substrates for CTC isolation (<a class="ext-link" href="/doi/suppl/10.1021/acsami.1c00577/suppl_file/am1c00577_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

A multifunctional platform for the capture, release, and enumeration of circulating tumor cells based on aptamer binding, nicking endonuclease-assisted amplification, and inductively coupled plasma mass spectrometry detection.

Self-Sterilizing and Regeneratable Microchip for the Precise Capture and Recovery of Viable Circulating Tumor Cells from Patients with Cancer.

A Cascaded Phase-Transfer Microfluidic Chip with Magnetic Probe for High-Activity Sorting, Purification, Release, and Detection of Circulating Tumor Cells

Aptamer-Based Dual-Functional Probe for Rapid and Specific Counting and Imaging of MCF-7 Cells

Simultaneous Detection of MCF-7 and HepG2 Cells in Blood by ICP-MS with Gold Nanoparticles and Quantum Dots As Elemental Tags.

Enrichment and Analysis of Circulating Tumor Cells by Integrating Multivalent Membrane Nano-Interface and Endogenous Enzyme-Signal Amplification

Multivalent Aptamer Functionalized Ag<sub>2</sub>S Nanodots/Hybrid Cell Membrane-Coated Magnetic Nanobioprobe for the Ultrasensitive Isolation and Detection of Circulating Tumor Cells

Generally Applicable Circulating Tumor Cell Enrichment and Identification Through a Membrane Glycoprotein-Targeting Strategy Combining Magnetic Isolation and Biological Orthogonality Labeling.

An integrated and renewable interface for capture, release and analysis of circulating tumor cells

Multifunctional Gold Nano-Cytosensor With Quick Capture, Electrochemical Detection, and Non-Invasive Release of Circulating Tumor Cells for Early Cancer Treatment

Designer tetrahedral DNA framework-based microfluidic technology for multivalent capture and release of circulating tumor cells

Nondestructive capture, release, and detection of circulating tumor cells with cystamine-mediated folic acid decorated magnetic nanospheres.

Direct Analysis of Rare Circulating Tumor Cells in Whole Blood Based on Their Controlled Capture and Release on Electrode Surface.

Effective Isolation, Label and Release of Multitype Circulating Tumor Cells Base on CdSe/ZnS Quantum Dots and Dual-antibody Modified Magnetic Nanoparticles

General Applicable Circulating Tumor Cell Enrichment and Identification Through the Membrane Glycoprotein-targeted Strategy Combining Magnetic Isolation and Biological Orthogonality Labeling

Immunodetection and counting of circulating tumor cells (HepG2) by combining gold nanoparticle labeling, rolling circle amplification and ICP-MS detection of gold

Dual-Multivalent-Aptamer-Conjugated Nanoprobes for Superefficient Discerning of Single Circulating Tumor Cells in a Microfluidic Chip with Inductively Coupled Plasma Mass Spectrometry Detection.

SERS and fluorescence detection of circulating tumor cells (CTCs) with specific capture-release mode based on multifunctional gold nanomaterials and dual-selective recognition

Bioinspired Nano-Plate-coral Platform Enabled Efficient Detection of Circulating Tumor Cells Via the Synergistic Capture of Multivalent Aptamer and Tumor Cell Membrane.

Beyond enumeration: Phenotype independent “labeling-capture-release” process enabling precise detection of circulating tumour cells and downstream applications

Highly Integrated Cell-Imprinted Biomimetic Interface for All-in-One Diagnosis of Heterogeneous Circulating Tumor Cells